BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32931001)

  • 1. Ultrastructural intestinal mucosa change after prolonged inhibition of gastric acid secretion by omeprazole in male rats.
    Chamniansawat S; Kampuang N; Suksridechacin N; Thongon N
    Anat Sci Int; 2021 Jan; 96(1):142-156. PubMed ID: 32931001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prolonged omeprazole administration on segmental intestinal Mg
    Suksridechacin N; Kulwong P; Chamniansawat S; Thongon N
    World J Gastroenterol; 2020 Mar; 26(11):1142-1155. PubMed ID: 32231419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypomagnesemia and hypoparathyroidism induced by omeprazole.
    Rodríguez Ortega P; Rebollo Pérez I; Laínez López M; Roldán Mayorga E; Hernández Lavado R; Creagh Cerquera R
    Endocrinol Nutr; 2013 Mar; 60(3):156-7. PubMed ID: 22627012
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole suppressed plasma magnesium level and duodenal magnesium absorption in male Sprague-Dawley rats.
    Thongon N; Penguy J; Kulwong S; Khongmueang K; Thongma M
    Pflugers Arch; 2016 Nov; 468(11-12):1809-1821. PubMed ID: 27866273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drugs affecting serum magnesium concentration].
    Kawamura Y
    Clin Calcium; 2012 Aug; 22(8):1211-6. PubMed ID: 22846357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury.
    Zhang S; Chao GQ; Lu B
    Rheumatol Int; 2013 Oct; 33(10):2513-21. PubMed ID: 23604681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypomagnesemia induced by proton pump inhibitors, diarrhea, and lactose intolerance].
    Cano Megías M; Alvarez Santirso R; Iglesias Lozano P; Carrasco De La Fuente M; Pérez López G
    Endocrinol Nutr; 2011 Dec; 58(10):550-4. PubMed ID: 21764396
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults.
    Pastorino A; Greppi F; Bergamo D; Versino E; Bo M; Pezzilli MS; Furno E; Rrodhe S; Isaia G
    J Am Geriatr Soc; 2015 Jan; 63(1):179-80. PubMed ID: 25597570
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In brief: PPI's and hypomagnesemia.
    Med Lett Drugs Ther; 2011 Apr; 53(1361):25. PubMed ID: 21464802
    [No Abstract]   [Full Text] [Related]  

  • 13. [Review: UPDATE on magnesium metabolism].
    Fatuzzo P; Zanoli L; Scollo V; Portale G; Gaudio A; Pani A; Granata A
    G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.
    McColl KE; Gillen D
    Gastroenterology; 2009 Jul; 137(1):20-2. PubMed ID: 19482105
    [No Abstract]   [Full Text] [Related]  

  • 15. Ingestion of guar-gum hydrolysate partially restores calcium absorption in the large intestine lowered by suppression of gastric acid secretion in rats.
    Hara H; Suzuki T; Kasai T; Aoyama Y; Ohta A
    Br J Nutr; 1999 Apr; 81(4):315-21. PubMed ID: 10999019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
    Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
    PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(5):322-6. PubMed ID: 22745572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of
    Yoshihara T; Oikawa Y; Kato T; Kessoku T; Kobayashi T; Kato S; Misawa N; Ashikari K; Fuyuki A; Ohkubo H; Higurashi T; Tateishi Y; Tanaka Y; Nakajima S; Ohno H; Wada K; Nakajima A
    Gut Microbes; 2020 Sep; 11(5):1385-1404. PubMed ID: 32515658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].
    Piezzi V; Kullak-Ublick GA; Glisenti P
    Internist (Berl); 2014 Feb; 55(2):199-205. PubMed ID: 24419536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux.
    Wetscher GJ; Hinder RA; Smyrk T; Perdikis G; Adrian TE; Profanter C
    Dig Dis Sci; 1999 Jun; 44(6):1132-5. PubMed ID: 10389684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.